127 related articles for article (PubMed ID: 9168303)
1. Expression of CD95(FAS) by gene transfer does not sensitize K562 to Fas-killing.
Munker R; Marini F; Jiang S; Savary C; Owen-Schaub L; Andreeff M
Hematol Cell Ther; 1997 Apr; 39(2):75-8. PubMed ID: 9168303
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia.
Lamy T; Liu JH; Landowski TH; Dalton WS; Loughran TP
Blood; 1998 Dec; 92(12):4771-7. PubMed ID: 9845544
[TBL] [Abstract][Full Text] [Related]
3. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415
[TBL] [Abstract][Full Text] [Related]
4. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
Robertson MJ; Manley TJ; Pichert G; Cameron C; Cochran KJ; Levine H; Ritz J
Leuk Lymphoma; 1995 Mar; 17(1-2):51-61. PubMed ID: 7539660
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of IL-32alpha increases natural killer cell-mediated killing through up-regulation of Fas and UL16-binding protein 2 (ULBP2) expression in human chronic myeloid leukemia cells.
Cheon S; Lee JH; Park S; Bang SI; Lee WJ; Yoon DY; Yoon SS; Kim T; Min H; Cho BJ; Lee HJ; Lee KW; Jeong SH; Park H; Cho D
J Biol Chem; 2011 Apr; 286(14):12049-55. PubMed ID: 21321117
[TBL] [Abstract][Full Text] [Related]
6. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
7. The susceptibility of Philadelphia chromosome positive cells to FAS-mediated apoptosis is not linked to the tyrosine kinase activity of BCR-ABL.
Gora-Tybor J; Deininger MW; Goldman JM; Melo JV
Br J Haematol; 1998 Dec; 103(3):716-20. PubMed ID: 9858222
[TBL] [Abstract][Full Text] [Related]
8. Fas involvement in cytotoxicity mediated by human NK cells.
Montel AH; Bochan MR; Hobbs JA; Lynch DH; Brahmi Z
Cell Immunol; 1995 Dec; 166(2):236-46. PubMed ID: 7497525
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells.
Oshimi Y; Oda S; Honda Y; Nagata S; Miyazaki S
J Immunol; 1996 Oct; 157(7):2909-15. PubMed ID: 8816396
[TBL] [Abstract][Full Text] [Related]
10. Fas/APO-1 (CD95)-mediated cytotoxicity is responsible for the apoptotic cell death of leukaemic cells induced by interleukin-2-activated T cells.
Komada Y; Zhou YW; Zhang XL; Chen TX; Tanaka S; Azuma E; Sakurai M
Br J Haematol; 1997 Jan; 96(1):147-57. PubMed ID: 9012700
[TBL] [Abstract][Full Text] [Related]
11. The role of FAS-mediated apoptosis in chronic myelogenous leukemia.
Selleri C; Maciejewski JP
Leuk Lymphoma; 2000 Apr; 37(3-4):283-97. PubMed ID: 10752980
[TBL] [Abstract][Full Text] [Related]
12. Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis.
Plumas J; Jacob MC; Chaperot L; Molens JP; Sotto JJ; Bensa JC
Blood; 1998 Apr; 91(8):2875-85. PubMed ID: 9531598
[TBL] [Abstract][Full Text] [Related]
13. CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout mice.
Behrens CK; Igney FH; Arnold B; Möller P; Krammer PH
J Immunol; 2001 Mar; 166(5):3240-7. PubMed ID: 11207278
[TBL] [Abstract][Full Text] [Related]
14. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?
Strand S; Hofmann WJ; Hug H; Müller M; Otto G; Strand D; Mariani SM; Stremmel W; Krammer PH; Galle PR
Nat Med; 1996 Dec; 2(12):1361-6. PubMed ID: 8946836
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer of tissue inhibitor of metalloproteinases-3 reverses the inhibitory effects of TNF-alpha on Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts.
Drynda A; Quax PH; Neumann M; van der Laan WH; Pap G; Drynda S; Meinecke I; Kekow J; Neumann W; Huizinga TW; Naumann M; König W; Pap T
J Immunol; 2005 May; 174(10):6524-31. PubMed ID: 15879156
[TBL] [Abstract][Full Text] [Related]
17. [An evaluation of the prognostic significance of antigen CD95(Fas/APO-1) expression on the cells of patients with a myelodysplastic syndrome, acute myeloid leukemia and chronic myeloleukemia].
Polosukhina ER; Kuznetsov SV; Logcheva NP; Zabotina TN; Tenuta MR; Shirin AD; Kaletin GI; Turkina AG; Tsvetaeva NV; Shishkin IuV; Kadagidze ZG; Khoroshko ND; Volkova MA; Baryshnikov AIu
Ter Arkh; 1998; 70(7):21-5. PubMed ID: 9742630
[TBL] [Abstract][Full Text] [Related]
18. Quercetin and anti-CD95(Fas/Apo1) enhance apoptosis in HPB-ALL cell line.
Russo M; Palumbo R; Tedesco I; Mazzarella G; Russo P; Iacomino G; Russo GL
FEBS Lett; 1999 Dec; 462(3):322-8. PubMed ID: 10622719
[TBL] [Abstract][Full Text] [Related]
19. Membrane-bound Fas (Apo-1/CD95) ligand on leukemic cells: A mechanism of tumor immune escape in leukemia patients.
Buzyn A; Petit F; Ostankovitch M; Figueiredo S; Varet B; Guillet JG; Ameisen JC; Estaquier J
Blood; 1999 Nov; 94(9):3135-40. PubMed ID: 10556200
[TBL] [Abstract][Full Text] [Related]
20. Novel Application of Radotinib for the Treatment of Solid Tumors via Natural Killer Cell Activation.
Kim KE; Park S; Cheon S; Kim DY; Cho DJ; Park JM; Hur DY; Park HJ; Cho D
J Immunol Res; 2018; 2018():9580561. PubMed ID: 30687767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
